Markets are rallying today in response to the U.S.–China tariff truce.

In the short term, equities could continue to rise, supported by light investor positioning and lingering pessimism. But looking further ahead, the bullish case for U.S. stocks hinges on the success of President Trump’s economic agenda.

Supporters argue that Trump will implement gradual spending cuts, lowering U.S. bond yields and easing pressure on government financing. Simultaneously, banking deregulation is expected to encourage credit growth and stimulate private-sector activity.

However, as TSLombard economist Dario Perkins notes, there are significant hurdles to this optimistic scenario:

1. Policy uncertainty is weighing on private consumption and investment.

2. Tariffs are contributing to inflation, constraining the Federal Reserve’s ability to ease policy.

3. Despite rhetoric on spending cuts, actual progress has been limited.

As a result, the U.S. economy is likely to slow further. While a recession may be avoided, tariffs are expected to remain elevated, limiting the Fed’s ability to respond with aggressive rate cuts.

In contrast, continued fiscal and monetary stimulus across the rest of the world should support non-U.S. assets. The portfolio is positioned accordingly to benefit from this divergence.

𝟮𝟬𝟮𝟱 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲
@triangulacapital +16.9%
SWDA.L +0.7%

𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗰𝗵𝗮𝗻𝗴𝗲𝘀
AstraZeneca was sold.

𝘛𝘩𝘪𝘴 𝘤𝘰𝘯𝘵𝘦𝘯𝘵 𝘪𝘴 𝘧𝘰𝘳 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯 𝘰𝘯𝘭𝘺. 𝘐𝘵 𝘪𝘴 𝘯𝘰𝘵 𝘢𝘯 𝘰𝘧𝘧𝘦𝘳 𝘰𝘳 𝘳𝘦𝘤𝘰𝘮𝘮𝘦𝘯𝘥𝘢𝘵𝘪𝘰𝘯 𝘵𝘰 𝘣𝘶𝘺, 𝘩𝘰𝘭𝘥 𝘰𝘳 𝘴𝘦𝘭𝘭 𝘢𝘯𝘺 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵, 𝘯𝘰𝘳 𝘭𝘦𝘨𝘢𝘭, 𝘵𝘢𝘹, 𝘰𝘳 𝘧𝘪𝘯𝘢𝘯𝘤𝘪𝘢𝘭 𝘢𝘥𝘷𝘪𝘤𝘦. 𝘗𝘢𝘴𝘵 𝘱𝘦𝘳𝘧𝘰𝘳𝘮𝘢𝘯𝘤𝘦 𝘪𝘴 𝘯𝘰𝘵 𝘪𝘯𝘥𝘪𝘤𝘢𝘵𝘪𝘷𝘦 𝘰𝘧 𝘧𝘶𝘵𝘶𝘳𝘦 𝘳𝘦𝘴𝘶𝘭𝘵𝘴.